We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 26 start-ups with an aggregate funding of $436.3m. The average funding per company in this subset is $16.8m.
Last update to the database: Feb 18, 2025. See changelog.
1
Funding Rounds
$12.5m
Money raised
Clinical Research & Services
2
Funding Rounds
$62.6m
Money raised
A company that develops and manufactures dental implant products
1
Funding Rounds
$1.8m
Money raised
Developer of a genomic risk prediction platform designed to democratize access to clinical-grade polygenic risk scores (PSRs). The company combines datasets with advanced algorithms to build PRSs with high predictive power for estimating disease risk and translating the potential of genomic data into practical tools.
8
Funding Rounds
$15.6m
Money raised
Diagnostic solutions developer for cancer patients using liquid biopsy technology.
$16.0m
Money raised
MOGU manufactures materials and technologies that are based on fungi as main constituent.
1
Funding Rounds
$40.6m
Money raised
Seed Health is a Venice-based microbial sciences company working on applications of bacteria for human and environmental health.
2
Funding Rounds
$778.8k
Money raised
NTP Nano Tech Projects SRL is a Rovereto-based company founded by Adolfo Carloni, Gianluca Maroncelli, Massimo Galavotti and Mauro Malan.
1
Funding Rounds
$1.2m
Money raised
Platform that helps doctors quickly diagnose and treat rare genetic diseases within 24 hours using AI.
6
Funding Rounds
$44.8m
Money raised
Microbion is a Verona-based microbiology service provider for agricultural, food, and pharmaceutical industry.
2
Funding Rounds
$1.8m
Money raised
Biogenera S.p.A is a biotechnology company focusing on the research and development of DNA-based medicines for the treatment of serious pathologies.
1
Funding Rounds
$23.0m
Money raised
Developer of patent-based software designed to apply algorithms and drug design protocols. The company's software focuses on drug discovery protocols based on original reaction path sampling and data reduction algorithms to avoid folding and thus bring the protein to degradation.
1
Funding Rounds
$4.8m
Money raised
Alia Therapeutics S.R.L. is a targeted Gene Editing founded in 2018 by Antonio Casini, Anna Cereseto and Gianluca Petris.
2
Funding Rounds
$39.0m
Money raised
A pharmaceutical company developing topical solutions for inflammatory and infectious diseases
3
Funding Rounds
$46.9m
Money raised
Pharmaceutical developer specializing in new treatments for chronic inflammatory diseases.
3
Funding Rounds
$11.1m
Money raised
Medical device manufacturer that creates tools for gastrointestinal endoscopy.
2
Funding Rounds
$43.5m
Money raised
Enthera is an IGFBP3 Inhibitors - Monoclonal Antibody, Fusion Proteins founded in 2016.
1
Funding Rounds
$2.1m
Money raised
Geneticlab is a Castenedolo, Italy-based genetics company.
4
Funding Rounds
$6.9m
Money raised
CellPly is a Bologna-based diagnostics company developing cell analysis for the efficacy of drug therapy founded in 2013 by Massimo Bocchi.
2
Funding Rounds
$590.0k
Money raised
Neuro-Zone is a pathology Services founded in 2007 by Fabio Bianco.
1
Funding Rounds
$11.0m
Money raised
Resalis Therapeutics is developing first-in-class anti-miR compounds to address high unmet medical needs in liver diseases, metabolic disorders, and cancer using a multi-pathway approach.
2
Funding Rounds
$9.6m
Money raised
Silicon Biosystems is an Italy-based company developing lab-on-a-chip technologies for miniaturized cell-biology testing.
1
Funding Rounds
$10.0m
Money raised
BetaGlue Technologies is a Verona-based company founded in 2009.
1
Funding Rounds
$1.6m
Money raised
RNA inhibitor-based therapeutics developer for treating intractable cancers and genetic conditions.
1
Funding Rounds
$18.0m
Money raised
Developer of a versatile, non-viral drug delivery platform based on inorganic nanoparticles.
1
Funding Rounds
$514.6k
Money raised
Instruments utilizing optical and electrooptical technology for scientific and industrial applications.
1
Funding Rounds
$10.0m
Money raised
Arsenale Bioyards is an end-to-end bio-manufacturing platform founded in 2023.
Enter your email and get access to 71,000 + technology companies you can partner with.